Thus, current evidences indicate that the Sirt1/Nrf2/ARE signaling pathway is important in the prevention and treatment of DN, and that the antioxidant activity of FMN and the agonistic effect of FMN on Sirt1 probably plays a significant role in this process. This evidence concerns the gene SIRT1 and liver dysplastic nodule.